MAGEH1 and central nervous system cancer: Treatment of GBM cell line U87MG and LN229 with DNA methyltransferase (DNMT) inhibitor 5-Azacytidine enhanced MAGEH1 mRNA expression thereby confirming the role of epigenetic regulation in MAGEH1 expression in glioma (Figure 4C).